etafilcon A (multi-focal)
DeviceEach subject will wear the soft contact lenses for 15 minutes then remove the lenses.
Other names: Investigational Multifocal Contact
NCT Number: NCT02310126
Subjects will evaluate each study lens in a random order. The lenses will be worn in both eyes for a short period.
Looking for future studies?
Notify Me40 year–70 year
All sexes
Interventional
Not applicable
Baymeadows Vision Center, Jacksonville, Florida, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each subject will wear the soft contact lenses for 15 minutes then remove the lenses.
Other names: Investigational Multifocal Contact
Each subject will wear the soft contact lenses for 15 minutes then remove the lenses.
Other names: 1-DAY ACUVUE® MOIST®
Time frame: 15 minutes post Contact Lens Insertion
CLUE Overall Lens Handling is assessed using the Contact Lens User Experience (CLUE)TM questionnaire. CLUE is a validated patient-reported outcomes questionnaire to assess patient experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response. 97% of the scores fall within 0 and 120 (mean +/-3XSD).
Johnson & Johnson Vision Care, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07723716
Eye Diseases, Presbyopia
Seoul, South Korea
View Trial DetailsNCT05646719
Eye Diseases, Presbyopia
Phoenix, Arizona, United States
View Trial DetailsNCT07076160
Eye Diseases, Presbyopia
Jacksonville, Florida, United States
View Trial DetailsNCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial Details